Pharmacological Therapy for Apathy in Alzheimer’s Disease: A Systematic Review and Meta-Analysis

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques

• Publication date

  2017-02-02

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1017/cjn.2016.426PMID 28148339
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Apathy associated with neurocognitive disorders: Recent progress and future directions

  2017cited by this paper
• Glutamatergic agents for schizophrenia: current evidence and perspectives

  2015cited by this paper
• Apathy in Neurodegenerative Diseases: Recommendations on the Design of Clinical Trials

  2015cited by this paper
• Apathy in Neurodegenerative Diseases

  2015cited by this paper
• The effects of combine treatment of memantine and donepezil on Alzheimer's Disease patients and its relationship with cerebral blood flow in the prefrontal area

  2014cited by this paper
• Differential Effects of Current Specific Treatments on Behavioral and Psychological Symptoms in Patients with Alzheimer's Disease: A 12-Month, Randomized, Open-Label Trial

  2014cited by this paper
• Apathy in Alzheimer's Disease: Any Effective Treatment?

  2014cited by this paper
• Glutamatergic drugs for schizophrenia treatment.

  2014cited by this paper
• Clinical trials and late‐stage drug development for Alzheimer's disease: an appraisal from 1984 to 2014

  2014cited by this paper
• A review of neuroimaging findings of apathy in Alzheimer's disease

  2013cited by this paper
• Safety and efficacy of methylphenidate for apathy in Alzheimer's disease: a randomized, placebo-controlled trial.

  2013cited by this paper
• A randomized, double-blind, placebo-controlled trial of memantine in a behaviorally enriched sample of patients with moderate-to-severe Alzheimer's disease

  2013cited by this paper
• Efficacy of increasing donepezil in mild to moderate Alzheimer's disease patients who show a diminished response to 5 mg donepezil: a preliminary study

  2013cited by this paper
• Pharmacologic treatment of apathy in dementia.

  2012cited by this paper
• A randomized, double-blind, placebo-controlled trial of modafinil for the treatment of apathy in individuals with mild-to-moderate Alzheimer's disease.

  2012cited by this paper
• Stay the course--is it justified?

  2012cited by this paper
• Nonpharmacological management of apathy in dementia: a systematic review.

  2012cited by this paper
• The serotonergic system in ageing and Alzheimer's disease.

  2012influential reference
• Apathy Syndrome in Alzheimer's Disease Epidemiology: Prevalence, Incidence, Persistence, and Risk and Mortality Factors

  2012cited by this paper
• Efficacy and Tolerability of Antidepressants in the Treatment of Behavioral and Psychological Symptoms of Dementia, A Literature Review of Evidence

  2011cited by this paper
• The Role of Dopamine in Symptoms and Treatment of Apathy in Alzheimer's Disease

  2011cited by this paper
• Are the available apathy measures reliable and valid? A review of the psychometric evidence.

  2011cited by this paper
• The Neuropsychiatric Inventory-Clinician rating scale (NPI-C): reliability and validity of a revised assessment of neuropsychiatric symptoms in dementia

  2010cited by this paper
• Methylphenidate for apathy and functional status in dementia of the Alzheimer type.

  2010cited by this paper
• Effects of rivastigmine on common symptomatology of Alzheimer’s disease (EXPLORE)

  2010cited by this paper
• Efficacy and Safety of Donepezil in Patients With Alzheimer’s Disease in Assisted Living Facilities

  2010cited by this paper
• Cholinergic modulation of the cerebral metabolic response to citalopram in Alzheimer's disease.

  2009cited by this paper
• Atomoxetine augmentation of cholinesterase inhibitor therapy in patients with Alzheimer disease: 6-month, randomized, double-blind, placebo-controlled, parallel-trial study.

  2009cited by this paper
• The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration

  2009cited by this paper
• Pharmacological Treatment of Apathy in Neurodegenerative Diseases: A Systematic Review

  2009cited by this paper
• Proposed diagnostic criteria for apathy in Alzheimer’s disease and other neuropsychiatric disorders

  2009cited by this paper
• Apathy predicts more severe parkinsonism in Alzheimer's disease.

  2009cited by this paper
• Are cholinesterase inhibitors effective in the management of the behavioral and psychological symptoms of dementia in Alzheimer's disease? A systematic review of randomized, placebo-controlled trials of donepezil, rivastigmine and galantamine

  2009cited by this paper
• The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration

  2009cited by this paper
• Effectiveness and safety of donepezil in Hispanic patients with Alzheimer's disease: a 12-week open-label study.

  2008cited by this paper
• Striatal dopamine transporter levels correlate with apathy in neurodegenerative diseases A SPECT study with partial volume effect correction.

  2008cited by this paper
• Neurobiology of apathy in Alzheimer's disease.

  2008cited by this paper
• Apathy associated with Alzheimer disease: use of dextroamphetamine challenge.

  2008cited by this paper
• Improvement in behavioural symptoms in patients with moderate to severe Alzheimer's disease by memantine: a pooled data analysis

  2008cited by this paper
• Neuroanatomical correlates of neuropsychiatric symptoms in Alzheimer's disease.

  2008cited by this paper
• Does analysis using “last observation carried forward” introduce bias in dementia research?

  2008cited by this paper
• A randomized, double-blind, placebo-controlled study of aripiprazole for the treatment of psychosis in nursing home patients with Alzheimer disease.

  2008cited by this paper
• The nosological position of apathy in clinical practice

  2008cited by this paper
• Quetiapine treatment for behavioural and psychological symptoms of dementia in Alzheimer's disease patients: a 6‐week, double‐blind, placebo‐controlled study

  2008cited by this paper
• Methylphenidate for the Treatment of Apathy in Alzheimer Disease: Prediction of Response Using Dextroamphetamine Challenge

  2008cited by this paper
• Neuropsychiatric Manifestations in Mild Cognitive Impairment: A Systematic Review of the Literature

  2007cited by this paper
• Development of a short version of the Apathy Evaluation Scale specifically adapted for demented nursing home residents.

  2007cited by this paper
• AMPA potentiator treatment of cognitive deficits in Alzheimer disease

  2007cited by this paper
• Positron emission tomography metabolic correlates of apathy in Alzheimer disease.

  2007cited by this paper
• Effectiveness of open-label donepezil treatment in patients with Alzheimer's disease discontinuing memantine monotherapy*

  2007cited by this paper
• A 2‐year open‐label study of galantamine therapy in Chinese Alzheimer's disease patients in Hong Kong

  2007cited by this paper
• Up-regulation of hippocampal serotonin metabolism in mild cognitive impairment

  2007cited by this paper
• A SPECT Study of Apathy in Alzheimer’s Disease

  2007cited by this paper
• Apathy and the functional anatomy of the prefrontal cortex-basal ganglia circuits.

  2006cited by this paper
• Behavioral effects of memantine in Alzheimer disease patients receiving donepezil treatment

  2006cited by this paper
• Involvement of the GABAergic system in depressive symptoms of Alzheimer's disease.

  2006cited by this paper
• Efficacy and safety of rivastigmine in the treatment of behavioural and psychological symptoms in Chinese dementia patients: An open-label study

  2006cited by this paper
• Propranolol for Disruptive Behaviors in Nursing Home Residents With Probable or Possible Alzheimer Disease: A Placebo-Controlled Study

  2005cited by this paper
• A prospective longitudinal study of apathy in Alzheimer’s disease

  2005cited by this paper
• Effects of rivastigmine treatment on the neuropsychiatric and behavioral disturbances of nursing home residents with moderate to severe probable Alzheimer's disease: a 26-week, multicenter, open-label study.

  2005cited by this paper
• On the overlap between apathy and depression in dementia

  2005cited by this paper
• Galantamine treatment of problematic behavior in Alzheimer disease: post-hoc analysis of pooled data from three large trials.

  2005cited by this paper
• Cholinergic-serotonergic imbalance contributes to cognitive and behavioral symptoms in Alzheimer's disease.

  2005cited by this paper
• GABAergic Function in Alzheimer's Disease: Evidence for Dysfunction and Potential as a Therapeutic Target for the Treatment of Behavioural and Psychological Symptoms of Dementia

  2004cited by this paper
• Comprehensive Meta-Analysis

  2004cited by this paper
• Cholinergic Drugs for Alzheimer's Disease Enhance in Vitro Dopamine Release

  2004cited by this paper
• Toward a molecular neuropsychiatry of neurodegenerative diseases

  2003cited by this paper
• A pilot open-label trial of citalopram for restless activity and aberrant motor behaviors in Alzheimer disease.

  2003cited by this paper
• Gabapentin for the Treatment of Behavioural Alterations in Dementia

  2003cited by this paper
• Cholinesterase Inhibitor Therapies and Neuropsychiatric Manifestations of Alzheimer’s Disease

  2003cited by this paper
• An informant-based assessment of apathy in Alzheimer disease.

  2002cited by this paper
• The Apathy Inventory: assessment of apathy and awareness in Alzheimer's disease, Parkinson's disease and mild cognitive impairment

  2002cited by this paper
• Syndromic validity of apathy in Alzheimer's disease.

  2001cited by this paper
• Serotonin-Dopamine Interactions in the Control of Conditioned Reinforcement and Motor Behavior

  2001cited by this paper
• A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer’s disease

  2001cited by this paper
• Long‐term efficacy of olanzapine in the control of psychotic and behavioral symptoms in nursing home patients with Alzheimer's dementia

  2001cited by this paper
• Cholinesterase inhibitors: A new class of psychotropic compounds.

  2000cited by this paper
• Apathy and Depression Following Stroke

  2000cited by this paper
• The cholinergic hypothesis of neuropsychiatric symptoms in Alzheimer's disease.

  1998cited by this paper
• Dopamine neurons and their role in reward mechanisms.

  1997cited by this paper
• The spectrum of behavioral changes in Alzheimer's disease

  1996cited by this paper
• Cerebral blood flow correlates of apathy in Alzheimer disease.

  1996cited by this paper
• The Neuropsychiatric Inventory

  1994cited by this paper
• Reliability, validity, and clinical correlates of apathy in Parkinson's disease.

  1992cited by this paper
• Functional status and clinical findings in patients with Alzheimer's disease.

  1992cited by this paper
• Reliability and validity of the Apathy Evaluation Scale.

  1991cited by this paper
• Apathy: a neuropsychiatric syndrome.

  1991cited by this paper

• Depression and apathy: examining an overlooked dimension.

  2026cites this paper
• Brief Behavioral Activation Therapy is effective on apathy symptoms of the older adults with mild Alzheimer’s disease but not with moderate Alzheimer’s disease

  2025cites this paper
• The Impact of eBook Clubs on Apathy Among Long Term Care Residents: A Pilot Study

  2025cites this paper
• Apathy in subarachnoid hemorrhage: study protocol for a 1-year follow-up study

  2024cites this paper
• Apathy in Alzheimer's disease: A Neurocircuitry Based Perspective.

  2023cites this paper
• Home-based tDCS for apathy in Alzheimer’s disease: a protocol for a randomized double-blinded controlled pilot study

  2023cites this paper
• Prevalence, treatment, and neural correlates of apathy in different forms of dementia: a narrative review

  2023cites this paper
• An Update on Apathy in Alzheimer’s Disease

  2023cites this paper
• A Systematic Review of Pharmacological Interventions for Apathy in Aging Neurocognitive Disorders

  2023cites this paper
• Methylphenidate and Other Pharmacologic Treatments for Apathy in Alzheimer's Disease.

  2022cites this paper
• Medication Management of Neuropsychiatric Symptoms in Neurological Conditions: A Dimensional Transdiagnostic Approach.

  2022cites this paper
• Efficacy of methylphenidate for the treatment of apathy in patients with Alzheimer’s disease: a systematic review and meta-analysis of randomized controlled studies

  2022cites this paper
• Non-pharmacological intervention effects on apathy caused by central nervous system organic diseases: A network meta-analysis

  2022cites this paper
• Rosmarinus officinalis and Methylphenidate Exposure Improves Cognition and Depression and Regulates Anxiety-Like Behavior in AlCl3-Induced Mouse Model of Alzheimer’s Disease

  2022cites this paper
• A Randomized Clinical Trial to Evaluate the Effects of Safinamide on Apathetic Non-demented Patients With Parkinson's Disease

  2022cites this paper
• Managing the Behavioral and Psychological Symptoms of Dementia

  2022cites this paper
• Emotion Processing Dysfunction in Alzheimer’s Disease: An Overview of Behavioral Findings, Systems Neural Correlates, and Underlying Neural Biology

  2022cites this paper
• Prevalent, persistent, and impairing: Longitudinal course and impact of apathy in Alzheimer's disease

  2021cites this paper
• Revisiting Apathy in Alzheimer's Disease: From Conceptualization to Therapeutic Approaches

  2021cites this paper
• Pharmacotherapy of Behavioral and Psychological Symptoms of Dementia: State of the Art and Future Progress

  2020cites this paper
• Pharmacologic Approaches for the Management of Apathy in Neurodegenerative Disorders

  2020cites this paper
• Stratégies thérapeutiques des troubles psychocomportementaux dans les troubles neurocognitifs de la personne âgée

  2019cites this paper
• Behavioral and psychological symptoms in Alzheimer's dementia and vascular dementia.

  2019cites this paper
• Unmet Needs in Pharmacological Treatment of Apathy in Alzheimer’s Disease: A Systematic Review

  2019cites this paper
• Translational approach to apathy‐like behavior in mice: From the practical point of view

  2019cites this paper
• Artful Moments: A framework for successful engagement in an arts-based programme for persons in the middle to late stages of dementia

  2019cites this paper
• Depression in Alzheimer’s Disease: An Alternative Role for Selective Serotonin Reuptake Inhibitors?

  2019cites this paper
• University of Birmingham Depression in Alzheimer's disease

  2019cites this paper
• Apathy in Alzheimer's disease

  2018cites this paper
• The Efficacy and Safety of Yokukansankachimpihange for Treating Behavioral and Psychological Symptoms of Dementia in Patients with Alzheimer’s Disease: An Open-Label Pilot Study

  2018cites this paper
• Photopharmacology in Alzheimer's Disease

  2018cites this paper
• Diagnosis and Management of Neuropsychiatric Symptoms in Alzheimer’s Disease

  2018cites this paper
• On the neural mechanisms of reduced behavior in people with cognitive decline

  2017cites this paper
• Pharmacological interventions for apathy in Alzheimer's disease.

  2016cites this paper